Matches in SemOpenAlex for { <https://semopenalex.org/work/W3204281142> ?p ?o ?g. }
- W3204281142 abstract "Objective: Hepatic encephalopathy (HE) is a neuropsychiatric syndrome caused by liver failure and by an impaired neurotransmission and neurological function caused by hyperammonemia (HA). HE, in turn, decreases the phosphorylation of protein kinase C epsilon (PKCε), contributing to the impairment of neuronal functions. Dehydroepiandrosterone (DHEA) exerts a neuroprotective effect by increasing the GABAergic tone through GABA A receptor stimulation. Therefore, we investigated the protective effect of DHEA in an animal model of HE, and the possible modulation of PKCε expression in different brain area. Methods: Fulminant hepatic failure was induced in 18 male, Sprague–Dawley rats by i.p. administration of 3 g/kg D-galactosamine, and after 30 min, a group of animals received a subcutaneous injection of 25 mg/kg (DHEA) repeated twice a day (3 days). Exploratory behavior and general activity were evaluated 24 h and 48 h after the treatments by the open field test. Then, brain cortex and cerebellum were used for immunoblotting analysis of PKCε level. Results: DHEA administration showed a significant improvement of locomotor activity both 24 and 48 h after D-galactosamine treatment ( **** p < 0.0001) but did not ameliorate liver parenchymal degeneration. Western blot analysis revealed a reduced immunoreactivity of PKCε ( * p < 0.05) following D-galactosamine treatment in rat cortex and cerebellum. After the addition of DHEA, PKCε increased in the cortex in comparison with the D-galactosamine-treated ( *** p < 0.001) and control group ( * p < 0.05), but decreased in the cerebellum ( * p < 0.05) with respect to the control group. PKCε decreased after treatment with NH 4 Cl alone and in combination with DHEA in both cerebellum and cortex ( **** p < 0.0001). MTS assay demonstrated the synergistic neurotoxic action of NH 4 Cl and glutamate pretreatment in cerebellum and cortex along with an increased cell survival after DHEA pretreatment, which was significant only in the cerebellum ( * p < 0.05). Conclusion: An association between the DHEA-mediated increase of PKCε expression and the improvement of comatose symptoms was observed. PKCε activation and expression in the brain could inhibit GABA-ergic tone counteracting HE symptoms. In addition, DHEA seemed to ameliorate the symptoms of HE and to increase the expression of PKCε in cortex and cerebellum." @default.
- W3204281142 created "2021-10-11" @default.
- W3204281142 creator A5014206961 @default.
- W3204281142 creator A5033718593 @default.
- W3204281142 creator A5043615929 @default.
- W3204281142 creator A5052798541 @default.
- W3204281142 creator A5058239611 @default.
- W3204281142 creator A5070652241 @default.
- W3204281142 creator A5088666492 @default.
- W3204281142 date "2021-09-28" @default.
- W3204281142 modified "2023-10-01" @default.
- W3204281142 title "Possible Association Between DHEA and PKCε in Hepatic Encephalopathy Amelioration: A Pilot Study" @default.
- W3204281142 cites W137575474 @default.
- W3204281142 cites W1552212921 @default.
- W3204281142 cites W1856209015 @default.
- W3204281142 cites W1966037459 @default.
- W3204281142 cites W1981436097 @default.
- W3204281142 cites W2000773358 @default.
- W3204281142 cites W2012923207 @default.
- W3204281142 cites W2015505702 @default.
- W3204281142 cites W2019027282 @default.
- W3204281142 cites W2029854919 @default.
- W3204281142 cites W2030486888 @default.
- W3204281142 cites W2031965957 @default.
- W3204281142 cites W2032212236 @default.
- W3204281142 cites W2038393276 @default.
- W3204281142 cites W2038457835 @default.
- W3204281142 cites W2039183451 @default.
- W3204281142 cites W2048373484 @default.
- W3204281142 cites W2059461481 @default.
- W3204281142 cites W2060382404 @default.
- W3204281142 cites W2082249282 @default.
- W3204281142 cites W2114070275 @default.
- W3204281142 cites W2132348584 @default.
- W3204281142 cites W2147746176 @default.
- W3204281142 cites W2153150744 @default.
- W3204281142 cites W2174032235 @default.
- W3204281142 cites W2340190517 @default.
- W3204281142 cites W2462805030 @default.
- W3204281142 cites W2571220349 @default.
- W3204281142 cites W3047577941 @default.
- W3204281142 cites W3094334480 @default.
- W3204281142 cites W4211058791 @default.
- W3204281142 cites W71370111 @default.
- W3204281142 cites W2157683814 @default.
- W3204281142 cites W2293871118 @default.
- W3204281142 doi "https://doi.org/10.3389/fvets.2021.695375" @default.
- W3204281142 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8505975" @default.
- W3204281142 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34651032" @default.
- W3204281142 hasPublicationYear "2021" @default.
- W3204281142 type Work @default.
- W3204281142 sameAs 3204281142 @default.
- W3204281142 citedByCount "1" @default.
- W3204281142 countsByYear W32042811422021 @default.
- W3204281142 crossrefType "journal-article" @default.
- W3204281142 hasAuthorship W3204281142A5014206961 @default.
- W3204281142 hasAuthorship W3204281142A5033718593 @default.
- W3204281142 hasAuthorship W3204281142A5043615929 @default.
- W3204281142 hasAuthorship W3204281142A5052798541 @default.
- W3204281142 hasAuthorship W3204281142A5058239611 @default.
- W3204281142 hasAuthorship W3204281142A5070652241 @default.
- W3204281142 hasAuthorship W3204281142A5088666492 @default.
- W3204281142 hasBestOaLocation W32042811421 @default.
- W3204281142 hasConcept C126322002 @default.
- W3204281142 hasConcept C134018914 @default.
- W3204281142 hasConcept C178790620 @default.
- W3204281142 hasConcept C185592680 @default.
- W3204281142 hasConcept C2776992908 @default.
- W3204281142 hasConcept C2777214474 @default.
- W3204281142 hasConcept C2777911890 @default.
- W3204281142 hasConcept C2778125326 @default.
- W3204281142 hasConcept C2779609443 @default.
- W3204281142 hasConcept C2779652256 @default.
- W3204281142 hasConcept C2780325230 @default.
- W3204281142 hasConcept C2781099255 @default.
- W3204281142 hasConcept C2781467277 @default.
- W3204281142 hasConcept C2911091166 @default.
- W3204281142 hasConcept C2911118192 @default.
- W3204281142 hasConcept C71315377 @default.
- W3204281142 hasConcept C71924100 @default.
- W3204281142 hasConceptScore W3204281142C126322002 @default.
- W3204281142 hasConceptScore W3204281142C134018914 @default.
- W3204281142 hasConceptScore W3204281142C178790620 @default.
- W3204281142 hasConceptScore W3204281142C185592680 @default.
- W3204281142 hasConceptScore W3204281142C2776992908 @default.
- W3204281142 hasConceptScore W3204281142C2777214474 @default.
- W3204281142 hasConceptScore W3204281142C2777911890 @default.
- W3204281142 hasConceptScore W3204281142C2778125326 @default.
- W3204281142 hasConceptScore W3204281142C2779609443 @default.
- W3204281142 hasConceptScore W3204281142C2779652256 @default.
- W3204281142 hasConceptScore W3204281142C2780325230 @default.
- W3204281142 hasConceptScore W3204281142C2781099255 @default.
- W3204281142 hasConceptScore W3204281142C2781467277 @default.
- W3204281142 hasConceptScore W3204281142C2911091166 @default.
- W3204281142 hasConceptScore W3204281142C2911118192 @default.
- W3204281142 hasConceptScore W3204281142C71315377 @default.
- W3204281142 hasConceptScore W3204281142C71924100 @default.
- W3204281142 hasLocation W32042811421 @default.
- W3204281142 hasLocation W32042811422 @default.
- W3204281142 hasLocation W32042811423 @default.